Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Mais filtros

Tipo de estudo
Intervalo de ano de publicação
Eur J Dermatol ; 2019 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-31475909


BACKGROUND: Actinic cheilitis (AC) is a chronic condition that affects mainly the lower lip. OBJECTIVES: To investigate the use of lip photoprotection in patients with AC. MATERIALS AND METHODS: A cross-sectional multicentre study of patients, ≥45 years of age, was performed in eight dermatology departments in the Galicia region over a period of one year. From 1,239 patients included in the study, 410 were diagnosed with AC and complete data were available for 408. An analysis of lip photoprotection habits and possible associations in patients with AC is reported. RESULTS: Mean age of patients with AC was 71.9 years and 53.8% were women. More than 90% of AC patients (370/408) had never used lip photoprotection. In the group of patients who used it, 62.16% of them had only used a single stick within the previous year. The only variable significantly associated with the use of lip sun protection was low Fitzpatrick's skin types I and II (p=0.039). Study limitations include the inclusion of patients 45 years or older and the use of a semiquantitative scale for measuring the frequency of application of lip photoprotection. CONCLUSIONS: To our knowledge, this is the first European study focused on lip photoprotection in patients suffering from AC. Only a minority of AC patients protect their lips from UV radiation. Specific lip sun protection recommendations should be promoted, especially in high-risk populations.

Acta Derm Venereol ; 98(10): 970-974, 2018 Nov 05.
Artigo em Inglês | MEDLINE | ID: mdl-30085328


Actinic cheilitis is thought to be a premalignant lesion or a superficial squamous cell carcinoma. The prevalence of actinic cheilitis in Europe is unknown. The aim of this study was to determine the prevalence of actinic cheilitis in the Galicia region (north-west Spain). Secondary objectives were the description of risk factors of actinic cheilitis. A cross-sectional multicentre study in patients ≥ 45 years of age was performed in 8 dermatology departments in Galicia region during a 1-year period. The prevalence of actinic cheilitis was 31.3%. Significant and independent risk factors of actinic cheilitis after multivariate analysis were age ≥ 60 years, Fitzpatrick skin phototype II, outdoor working for more than 25 years, and previous history of non-melanoma skin cancer. This is the first cross-sectional multicentre study of the prevalence of actinic cheilitis in Europe. Actinic cheilitis was present in almost one-third of the screened patients. Lip examination should be performed in all patients with chronic actinic damage.

Acta Dermatovenerol Croat ; 26(1): 61-63, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29782303


Clindamycin is a lincomycin-derived antibiotic useful for the treatment of anaerobic and Gram-positive aerobic bacterial infections. Cutaneous adverse reactions are usually maculopapular exanthemas, although hypersensitivity syndrome, acute generalized exanthematous pustulosis, and Stevens-Johnson syndrome have also been reported (1). We report the case of a patient with a maculopapular rash triggered by clindamycin who developed cutaneous lesions on striae distensae (SD). A 47-year-old woman was referred to our clinic for pruritic cutaneous lesions which had started 6 days earlier. Her past clinical history included hypertension, hypothyroidism, hyperuricemia, cholecystectomy, caesarean section, and endometriosis-related abdominal surgery, and she was taking levothyroxine, allopurinol, imidapril, and omeprazole. The skin rash first developed on her neck and back on the 3rd day of clindamycin oral treatment (300 mg every 6 hours), which was prescribed as antibiotic prophylaxis for a tooth implant. General malaise (but not fever) was also reported. Physical examination revealed an erythematous maculopapular eruption symmetrically distributed on the neck, abdomen, and back (Figure 1, A), with isolated lesions involving the proximal upper and lower limbs (Figure 1, B). There was a striking vertical distribution of skin lesions along the SD on the lateral sides of the abdomen (Figure 1, C). No mucosal involvement was found, and laboratory studies showed no abnormalities. Clindamycin withdrawal was followed by prescription of a course of oral deflazacort, starting at 30 mg daily and tapering down during a 9-day period. On the 5th day of treatment, the rash had almost cleared with minimal desquamation (Figure 1, D). Eight weeks after clearance of the skin rash, informed consent was obtained in order to perform an allergological evaluation of clindamycin, including prick and intradermal (ID) tests on the forearm and patch tests on the upper back (2). For patch testing, powder of the commercial capsules (Dalacin®) was diluted in petrolatum (pet.) and water (aq.), resulting in a final 1% clindamycin dilution. Parenteral clindamycin preparations were used in therapeutic concentrations for prick tests (150 mg/mL) and dilutions in saline of 1/100 and 1/10 for the ID test. Other authors have reported that these concentrations do not seem to irritate the skin (3-6). Prick and ID tests were assessed after 20 min and 24 hours, respectively. Patch tests were removed after the 2nd day, and late reactions were evaluated on day 2 and day 4. Prick and ID test results after 20 min were negative. Late results of ID tests with clindamycin (1.5 and 15 mg/mL) were positive: erythematous infiltrated papules about 7×7 mm and 18×15 mm were observed at 24 hours and lasted until the 8th day. Patch tests with clindamycin 1% in pet. and 1% in aq. were also positive (+ on day 2 and day 4). Positive late skin tests suggested delayed-type non-IgE-mediated allergic clindamycin hypersensitivity. Oral challenge tests are considered to be the gold standard to establish or exclude drug hypersensitivity. Due to the positive result of late skin test to clindamycin, oral challenge was not performed in our patient (3,5). The Koebner isomorphic phenomenon has been described in cutaneous reactions induced by drugs, such as antibiotics and chemotherapy. Chronic pressure on the skin is probably involved in the onset of skin lesions in hand-foot eruptions induced by tyrosine kinase inhibitors (sorafenib and sutinib). Solar exposure and cutaneous trauma also seem to play a role in the location of papulopustular eruptions caused by endothelial growth factor receptor inhibitors (erlotinib) (7). More frequent involvement in traumatized skin and surgical scars has been reported in the context of linear IgA bullous dermatosis and leukocytoclastic vasculitis triggered by vancomycin and cefuroxime (8). SD are produced by non-penetrating physical trauma, similar to friction or pressure. Different dermatoses can develop along SD skin lesions (like plaque psoriasis, pustular psoriasis, lichen planus, vitiligo, discoid lupus erythematosus, lupus vasculitis, urticarial vasculitis, or chronic graft-versus-host disease) (9). Bevacizumab, etretinate, and corticosteroid-induced ulcers, hyperpigmentation caused by bleomycin, and urticariform lesions triggered by diclofenac are examples of different type of drug-induced abnormalities involving SD (10). In summary, we identified clindamycin as the cause of the cutaneous reactions that occurred in our patient on the basis of the results of the skin tests and clinical history. Our findings confirmed a delayed-type hypersensitivity reaction, possibly involving a T-cell-mediated immunologic mechanism. Intradermal and patch tests were found to be useful in order to confirm the diagnosis (4,5). We did not find reports in the literature of drug-induced cutaneous eruptions along the SD as a manifestation of a Koebner phenomenon. Clinical underreporting of this phenomenon could explain the scarce literature on this cutaneous adverse reaction.

Clindamicina/efeitos adversos , Erupção por Droga/etiologia , Testes do Emplastro/métodos , Estrias de Distensão/etiologia , Administração Oral , Biópsia por Agulha , Clindamicina/uso terapêutico , Relação Dose-Resposta a Droga , Esquema de Medicação , Erupção por Droga/patologia , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Medição de Risco , Índice de Gravidade de Doença , Estrias de Distensão/patologia , Suspensão de Tratamento
Rev. int. cienc. podol. (Internet) ; 10(1): 26-30, 2016. ilus
Artigo em Espanhol | IBECS | ID: ibc-146001


La estucoqueratosis es una patología dérmica que cursa con tumoraciones queratósicas asintomáticas, benignas, blanco-grisáceas y de pequeño tamaño. Éstas suelen localizarse en las extremidades (especialmente en las inferiores) en torno al tobillo. Su etiología es desconocida y su diagnóstico se realiza mediante una correcta anamnesis y exploración física ya que la morfología, localización y edad de presentación son claves para poder establecer un diagnóstico diferencial con otras afecciones aunque en caso necesario también se puede recurrir a la biopsia. Constituye una entidad clínica con especial interés podológico dada su frecuente aparición en las extremidades inferiores, de ahí la necesidad de conocerla y de saber realizar un correcto diagnóstico diferencial. Presentamos el caso de un varón de 45 años sin antecedentes dermatológicos que presenta estucoqueratosis en la extremidad inferior y que acude al Servicio de Dermatología del Hospital Naval de Ferrol (AU)

Stucco keratosis is a dermal pathology that causes small, white-greyish, asymptomatic benign keratotic tumors. These are usually located in the extremities (especially in the lower) around the ankle. Its etiology is unknown and diagnosis is made through a proper clinical history and physical examination as morphology, location and age of presentation are key to establishing a diferential diagnosis with other conditions although if necessary biopsy is also avalaible. Stucco keratosis is a clinical entity with special podiatric interest given its frequent appearance in the lower extremities, hence the need to know and be able to perform a correct differential diagnosis. We report the case of a 45 year old man with no previous dermatological history presenting stucco keratosis in the lower extremity admitted to the outpatient clinic in the Dermatology Department of the Naval Hospital of Ferrol (AU)

Humanos , Masculino , Pessoa de Meia-Idade , Ceratose/diagnóstico , Podiatria/métodos , Diagnóstico Diferencial , Acantose Nigricans/diagnóstico , Papiloma/diagnóstico , Verrugas/diagnóstico
Pediatr Dermatol ; 28(6): 707-10, 2011 Nov-Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21906144


We report a 7-year-old boy with a past medical history of B-cell leukemia with dysmorphic features, including cleft palate, hypotrichosis with trichorrhexis nodosa, hypohidrosis, oligodontia, and ridging of nails. A heterozygous germline mutation, Ala111Thr, in the p63 gene was detected in the boy and in his mother, who had no clinical expression. This case emphasizes the spectrum of different phenotypical manifestations of mutations in the p63 gene and underlines the possible role of this gene as a tumor suppressor.

Displasia Ectodérmica/genética , Heterozigoto , Leucemia de Células B/genética , Mutação Puntual , Fatores de Transcrição/genética , Proteínas Supressoras de Tumor/genética , Adulto , Criança , Fenda Labial/genética , Fissura Palatina/genética , Feminino , Mutação em Linhagem Germinativa , Humanos , Masculino
Cutis ; 87(6): 287-8, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21838085


Onycholysis is the distal and/or lateral separation of the nail from the nail bed. Although it can be idiopathic, there are several factors associated with the development of this condition. Ischemia is recognized as one of the possible causes, but this relationship has been poorly described in the literature. We report a case of onycholysis with a striking clinical picture and discuss the role of ischemia in the development of the lesions.

Mãos/irrigação sanguínea , Onicólise/diagnóstico , Idoso , Diagnóstico Diferencial , Feminino , Humanos
Dermatol Online J ; 15(10): 7, 2009 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-19951625


Epidermal nevus syndrome is a rare congenital sporadic neurocutaneous disorder characterized by an epidermal nevus and various developmental abnormalities of the skin, eyes, nervous, cardiovascular and urogenital systems. We describe a patient with an extensive epidermal nevus associated with various organ abnormalities, particularly polyostotic fibrous dysplasia, central nervous system lipoma, and aplasia cutis. Our patient demonstrates the polymorphic spectrum of involvement in epidermal nevus syndrome.

Displasia Ectodérmica/complicações , Displasia Fibrosa Poliostótica/complicações , Lipoma/complicações , Neoplasias Primárias Múltiplas , Nevo/complicações , Neoplasias Cutâneas/complicações , Neoplasias da Medula Espinal/complicações , Adulto , Humanos , Masculino
J Cutan Pathol ; 36(2): 251-6, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18715254


BACKGROUND: Folliculo-sebaceous cystic hamartoma (FSCH) is an uncommon skin condition presenting as a slow-growing papulo-nodular lesion, in or around the nose. Most cases are not clinically suspected and only histopathological examination allows the diagnosis. Pathological features include a dermal-located infundibulo-cystic structure with sebaceous glands radiating around, a stromal component encircling the epithelial structures, with clefts between the lesional epithelial and stromal parts, as well as between this and the adjacent dermis. RESULTS: We report eight patients with the diagnosis of FSCH (5 females and 3 males), with ages ranging from 35 to 77 years. Most cases (5 out of 8) were located in or around the nose and sizes were comprised between 0.6 and 1.2 cm. Lesions had grown for long periods of time, up to ten years in one case. Immunohistochemistry showed staining for p63 in the epithelial component of all lesions, while CD10 was only present in some sebocytes. CD34 and Factor XIIIa positive cells were present in the lesional stroma. Staining for androgen and alpha-estrogen receptors was also usually noticed. CONCLUSIONS: FCSH is a hamartomatous skin lesion, clinically indistinct but with well-defined histopathological features. Immunohistochemistry shows a profile very close to normal sebaceous glands.

Cisto Epidérmico , Hamartoma , Proteínas de Neoplasias/metabolismo , Neoplasias Nasais , Neoplasias das Glândulas Sebáceas , Adulto , Idoso , Antígenos CD34/metabolismo , Cisto Epidérmico/metabolismo , Cisto Epidérmico/patologia , Fator XIIIa/metabolismo , Feminino , Hamartoma/metabolismo , Hamartoma/patologia , Humanos , Imuno-Histoquímica , Masculino , Proteínas de Membrana/metabolismo , Pessoa de Meia-Idade , Neprilisina/metabolismo , Neoplasias Nasais/metabolismo , Neoplasias Nasais/patologia , Receptores Androgênicos/metabolismo , Receptores Estrogênicos/metabolismo , Neoplasias das Glândulas Sebáceas/metabolismo , Neoplasias das Glândulas Sebáceas/patologia
Dermatitis ; 19(3): 154-6, 2008 May-Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18627689


We report three new cases of allergic contact dermatitis due to vitamins in cosmetic creams. The first patient was diagnosed with worsening rosacea but had allergic contact dermatitis from alpha-tocopherol in a moisturizing cream. The second and third cases presented as acute eyelid dermatitis due to vitamin K in eyelid lifter creams. Repeated open application testing and patch tests with the actual products and individual components of the creams were useful in establishing the diagnosis.

Cosméticos/efeitos adversos , Dermatite Alérgica de Contato/etiologia , Fármacos Dermatológicos/efeitos adversos , Dermatoses Faciais/etiologia , Vitamina K/efeitos adversos , Vitaminas/efeitos adversos , alfa-Tocoferol/efeitos adversos , Adulto , Dermatite Alérgica de Contato/diagnóstico , Face/patologia , Dermatoses Faciais/diagnóstico , Feminino , Humanos , Pessoa de Meia-Idade , Testes do Emplastro , Pele/patologia